| SpliceBio S.L.. (6/11/25). "Press Release: SpliceBio Secures $135 Million Series B Financing to Advance Lead Program SB-007 in Stargardt Disease and Expand Pipeline of Genetic Medicines". Barcelona. |
2025-06-11 |
| Mosanna Therapeutics, Inc.. (6/9/25). "Press Release: Mosanna Therapeutics Launches with $80 Million to Advance Novel Nighttime Nasal Spray for Obstructive Sleep Apnea". Redwood City, CA. |
2025-06-09 |
| Immunic, Inc.. (6/2/25). "Press Release: Immunic to Participate in Investor, Scientific and Industry Conferences in June". New York, NY. |
2025-06-02 |
| GlycoEra AG. (5/27/25). "Press Release: GlycoEra AG Raises $130 Million to Advance Novel Pipeline of Extracellular Protein Degraders for the Treatment of Autoimmune Diseases". Newton, MA & Wädenswil. |
2025-05-27 |
| ReproNovo SA. (5/21/25). "Press Release: ReproNovo Raises $65 Million Series A Financing to Advance Phase 2 Clinical Trials of Novel Therapies in Reproductive Medicine and Women’s Health". Lausanne & Copenhagen. |
2025-05-21 |
| Faron Pharmaceuticals Oy. (5/21/25). "Press Release: Faron Appoints Ralph Hughes as Chief Business Officer (CBO)". Turku. |
2025-05-21 |
| Augustine Therapeutics N.V.. (5/21/25). "Press Release: Augustine Therapeutics Appoints Rie Schultz Hansen, PhD, as Chief Scientific Officer and Establishes Copenhagen-based Subsidiary". Leuven. |
2025-05-21 |
| PeptiSystems AB. (5/15/25). "Press Release: PeptiSystems and Asahi Kasei Bioprocess America Enter Exclusive Global Partnership for Peptide Synthesis". Uppsala. |
2025-05-15 |
| Novo Holdings A/S. (4/24/25). "Press Release: Novo Holdings and EIFO Invest €48 Million in HealthCap IX to Strengthen the Nordic Life Sciences Ecosystem". |
2025-04-24 |
| Oryzon Genomics S.A.. (4/24/25). "Press Release: Oryzon Raises €30 Million in Capital Increase". Madrid & Cambridge, MA. |
2025-04-24 |
| Biotage AB. (4/22/25). "Press Release: Statement by the Board of Directors of Biotage in Relation to the Public Offer from RWK BidCo". |
2025-04-22 |
| Glycomine, Inc.. (4/16/25). "Press Release: Glycomine Announces $115 Million Series C Financing to Advance Lead Drug Candidate, GLM101, into a Phase 2b Clinical Trial for PMM2-CDG". San Carlos, CA. |
2025-04-16 |
| Meribel Pharma Solutions. (4/15/25). "Press Release: Meribel Pharma Solutions Launches with Big Ambitions to Elevate Pharma Services to New Heights". |
2025-04-15 |
| ExpreS2ion Biotech Holding AB. (4/15/25). "Press Release: ExpreS2ion Signs Letter of Intent with WuXi Vaccines to Initiate Technology Evaluation of ExpreS2ion’s Proprietary Production Platform ExpreS2". Hørsholm. |
2025-04-15 |
| Bühlmann Laboratories AG. (4/8/25). "Press Release: Bühlmann Laboratories AG Appoints Christian Eberle as CEO". |
2025-04-08 |
| Bico Group AB. (4/4/25). "Press Release: Bico Has Entered into an Agreement to Divest MatTek to Sartorius for USD 80m". |
2025-04-04 |
| ExpreS2ion Biotech Holding AB. (4/1/25). "Press Release: ExpreS2ion Provides Pipeline Update". Hørsholm. |
2025-04-01 |
| Amboss SE. (3/25/25). "Press Release: Amboss Closes €240M Financing Round and Expands Its Position as the Leading Co-pilot for Physicians Worldwide". Berlin & New York, NY. |
2025-03-25 |
| Augustine Therapeutics N.V.. (3/24/25). "Press Release: Augustine Therapeutics Raises Oversubscribed EUR 78 Million / USD 85 Million Series A Financing Round". Leuven. |
2025-03-24 |
| Genmab A/S. (3/22/25). "Press Release: Genmab to Vigorously Defend Alleged Claims of Trade Secret Misappropriation by AbbVie Inc.". Copenhagen. |
2025-03-22 |
| [iito] Business Intelligence. (3/18/25). "Press Release: [iito] Business Intelligence Announces Major Changes in Its Social Media Strategy". Bremen. |
2025-03-18 |
| Vivesto AB. (3/18/25). "Press Release: Vivesto Licenses Apealea to China’s Zhida Pharmaceutical". Solna. |
2025-03-18 |
| Salipro Biotech AB. (3/13/25). "Press Release: Salipro Biotech and Boehringer Ingelheim Enter Research and License Agreement to Accelerate Multiple Boehringer Ingelheim Pipeline Programs". Stockholm. |
2025-03-13 |
| Valo Therapeutics Oy. (3/10/25). "Press Release: Valo Therapeutics Announces EUR 19m of Investment Funding and Expanded Clinical Trials". Helsinki, Naples & Perth. |
2025-03-10 |
| Salipro Biotech AB. (3/5/25). "Press Release: Collaboration and Licensing Agreement with Top Tier South Korean Pharma Company". |
2025-03-05 |
| Callio Therapeutics. (3/3/25). "Press Release: Callio Therapeutics Launches with US$187 Million Series A to Advance Multi-Payload Antibody-Drug Conjugate Platform Through Clinical Proof-of-Concept". Seattle, WA & Singapore. |
2025-03-03 |
| FoRx Therapeutics AG. (2/26/25). "Press Release: FoRx Therapeutics Appoints Chief Medical Officer and Provides an Update on Its Lead Development Candidate". Basel. |
2025-02-26 |
| Adcendo ApS. (2/26/25). "Press Release: Adcendo ApS Announces U.S. FDA Clearance of IND Application for Phase I Tiffany-01 Trial of ADCE-T02". Copenhagen. |
2025-02-26 |
| Fuse Vectors ApS. (2/25/25). "Press Release: Fuse Vectors Secures $5.2m to Advance Cell-free Gene therapy Technology, Led by HCVC". Copenhagen. |
2025-02-25 |
| FibroGen, Inc.. (2/20/25). "Press Release: FibroGen Announces the Sale of FibroGen China to AstraZeneca for Approximately $160 Million". San Francisco, CA. |
2025-02-20 |
| Ginkgo Bioworks Inc.. (2/20/25). "Press Release: Ginkgo Bioworks Partners with HaDEA in Up to €24 Million Consortium Project to Deliver Next-Generation 'Agnostic Diagnostics' for Respiratory Viruses at the Point of Care". Boston, MA. |
2025-02-20 |
| Augustine Therapeutics N.V.. (2/13/25). "Press Release: Augustine Therapeutics Appoints Gerhard Koenig as Chief Executive Officer as Company Prepares to Enter the Clinic". Leuven. |
2025-02-13 |
| Oculis Holding AG. (2/13/25). "Press Release: Oculis Announces Pricing of $100 Million Oversubscribed Offering of Ordinary Shares". Zug. |
2025-02-13 |
| SiteOne Therapeutics, Inc.. (2/4/25). "Press Release: SiteOne Therapeutics Announces Positive Phase 1 Clinical Data for STC-004, a Novel NaV1.8 Inhibitor in Development for the Non-Opioid Treatment of Pain". South San Francisco, CA. |
2025-02-04 |
| Evaxion Biotech A/S. (1/31/25). "Press Release: Evaxion Announces Closing of $10.8 Million Public Offering". Copenhagen. |
2025-01-31 |
| Evaxion Biotech A/S. (1/30/25). "Press Release: Evaxion Announces Pricing of $10.8 Million Public Offering". Copenhagen. |
2025-01-30 |
| Evaxion Biotech A/S. (1/28/25). "Press Release: Evaxion Granted 180-day Compliance Extension by Nasdaq as It Restores Equity above Minimum Requirement". Copenhagen. |
2025-01-28 |
| Forbion Capital Partners. (1/27/25). "Press Release: Forbion BioEconomy Fund I Surpasses €150 Million Target, Raising €164.5 Million with Strong Institutional LP Support". Naarden. |
2025-01-27 |
| Arctic Therapeutics. (1/22/25). "Press Release: Arctic Therapeutics Announces €26.5M Oversubscribed Series A Financing". Reykjavik & Philadelphia, PA. |
2025-01-22 |
| Medix Biochemica Oy. (1/22/25). "Press Release: Medix Biochemica Expands Its Offering of Critical IVD Raw Materials to Premium Blockers and Stabilizers by Acquiring Candor Bioscience". Espoo. |
2025-01-22 |
| Circio Holding ASA. (1/21/25). "Press Release: 4basebio Partners with Circio to Build and Test circVec Synthetic DNA Vectors for Genetic Medicine and Vaccines". Oslo. |
2025-01-21 |
| bioMérieux S.A.. (1/13/25). "Press Release: bioMérieux Strengthens Its Point of Care Presence with the Acquisition of the Immunoassay Start-up SpinChip". Marcy l’Étoile. |
2025-01-13 |
| bioMérieux S.A.. (1/13/25). "Press Release: bioMérieux to Present at the 43rd Annual J.P. Morgan HealthCare Conference". Marcy l’Étoile. |
2025-01-13 |
| bioMérieux S.A.. (1/13/25). "Press Release: SpinChip Diagnostics to be Acquired by bioMérieux". Oslo. |
2025-01-13 |
| Windward Bio AG. (1/10/25). "Press Release: Windward Bio Launches With $200 Million Series A Financing to Develop Phase 2-Ready, Long-Acting Anti-TSLP Antibody With Best-in-Class Potential in Asthma and COPD". Basel. |
2025-01-10 |
| Numab Therapeutics AG. (1/9/25). "Press Release: Numab Therapeutics Announces Series C Extension to CHF 180 Million, Completing Oversubscribed CHF 50 Million Financing". Horgen. |
2025-01-09 |
| Coave Therapeutics (Horama S.A.). (1/9/25). "Press Release: Coave Therapeutics Secures €32 Million ($33 Million) in Series A Financing to Advance its Next-Generation Genetic Medicines". Paris. |
2025-01-09 |
| Neumirna Therapeutics ApS. (1/8/25). "Press Release: Neumirna Therapeutics secures €20M in Series A financing to develop RNA therapies for epilepsy and other neurological disorders". Copenhagen. |
2025-01-08 |
| Argobio SAS. (1/7/25). "Press Release: Next-generation RNA Company Inverna Therapeutics Launched by Argobio and University of Southern Denmark". Odense. |
2025-01-07 |
| Orbis Medicines ApS. (1/6/25). "Press Release: Orbis Medicines Raises EUR 90 Million Series A Funding Round to Develop Pipeline of Oral Macrocycles". Copenhagen. |
2025-01-06 |
| Y-mAbs Therapeutics, Inc.. (12/23/24). "Press Release: Y-mAbs to Present at the 43rd Annual J.P. Morgan Healthcare Conference". New York, NY. |
2024-12-23 |
| SiteOne Therapeutics, Inc.. (12/18/24). "Press Release: SiteOne Therapeutics Announces a $100 Million Series C Financing to Advance Selective Ion Channel Modulators as Non-opioid Treatments for Pain". South San Francisco, CA. |
2024-12-18 |
| Evaxion Biotech A/S. (12/17/24). "Press Release: Evaxion Pursues Agreement with EIB to Bolster Equity through Conversion of Debt into Equity". Copenhagen. |
2024-12-17 |
| 2cureX AB. (12/16/24). "Press Release: 2cureX AB Announces the Appointment of Dan Honeywell as CEO, Ushering in a New Era of Commercial Expansion of Breakthrough Precision Oncology Products". |
2024-12-16 |
| Gilde Healthcare Partners. (12/16/24). "Press Release: Gilde Healthcare Invests alongside Capital A in Tromp Medical to Accelerate International Growth in the Medical Imaging Market". Utrecht. |
2024-12-16 |
| Single Use Support GmbH. (12/16/24). "Press Release: Darren Verlenden New CEO of Single Use Support". Kufstein. |
2024-12-16 |
| Pharming Group N.V.. (12/15/24). "Press Release: Pharming Announces Public Cash Offer to the Shareholders of Abliva AB". Leiden. |
2024-12-15 |
| EQT AB. (12/11/24). "Press Release: EQT Life Sciences Leads Series B Extension in Noema Pharma, Raising Total Series B Financing to CHF 130 million". |
2024-12-11 |
| Evotec SE. (12/11/24). "Press Release: Evotec SE Announces First Projects for LAB eN² Drug Discovery Accelerator with Novo Nordisk". Pratteln. |
2024-12-11 |
| Muna Therapeutics ApS. (12/5/24). "Press Release: Muna Therapeutics Announces Strategic Alliance with GSK to Accelerate Development of Novel Treatments for Alzheimer’s Disease". Copenhagen. |
2024-12-05 |
| Antag Therapeutics ApS. (12/4/24). "Press Release: Antag Therapeutics Announces €80 Million Series A Financing". Copenhagen. |
2024-12-04 |
| miDiagnostics N.V.. (12/4/24). "Press Release: miDiagnostics Secures €30 Million Series D Funding Round Led by Thermo Fisher Scientific to Advance an Innovative Sterility Test and Other Quality Control Tests for use in the BioPharma Industry". Leuven. |
2024-12-04 |
| H. Lundbeck A/S. (11/18/24). "Press Release: Lundbeck Announces Expiration of Longboard Tender Offer and That All Tender Offer Conditions Are Fulfilled". |
2024-11-28 |
| Saniona AB. (11/26/24). "Press Release: Saniona Announces Licensing Agreement with Acadia Pharmaceuticals for SAN711 in Neurological Diseases". |
2024-11-26 |
| Cradle Bio B.V.. (11/26/24). "Press Release: Cradle Raises $73m Series B Led by IVP to Accelerate Adoption of AI-powered Protein Engineering". Amsterdam & Zurich. |
2024-11-26 |
| Acadia Pharmaceuticals Inc.. (11/26/24). "Press Release: Acadia Pharmaceuticals Announces Exclusive License Agreement with Saniona for SAN711". San Diego, CA. |
2024-11-26 |
| Adragos Pharma GmbH. (11/25/24). "Press Release: Adragos Pharma Acquires Baccinex – a Leading Swiss Sterile Fill-Finish Expert". Munich & Courroux. |
2024-11-25 |
| Bico Group AB. (11/25/24). "Press Release: Cellink Announces Further Right-sizing and Launches Sharpened Commercial Agenda". |
2024-11-25 |
| Adcendo ApS. (11/25/24). "Press Release: Adcendo ApS Completes Oversubscribed $135 Million Series B Financing to Advance First-in-class ADC Pipeline". Copenhagen. |
2024-11-25 |
| Bico Group AB. (11/21/24). "Press Release: Bico Has Entered into an Agreement to Divest Nanoscribe". |
2024-11-21 |
| Mabel AI AB. (11/18/24). "Press Release: Partnership with Tolkförmedling Väst, the Largest Swedish Public Interpretation Agency, to Offer AI-based Interpretation in West Sweden". |
2024-11-18 |
| [iito] Business Intelligence / Kääb, Georg [ Itranskript ]. (11/13/24). "[LSG] Newsletter Special Issue: DACH Region Seed Financings 2020–2024. A List of 104 Deals with Comment & Analysis by Georg Kääb". Bremen & München. |
2024-11-13 |
| Alentis Therapeutics AG. (11/12/24). "Press Release: Alentis Therapeutics Raises $181.4 Million in an Oversubscribed Series D Financing to Advance the Clinical Development of Anti-Claudin-1 ADCs in Solid Tumors". Basel. |
2024-11-12 |
| Kivu Bioscience. (10/28/24). "Kivu Bioscience Raises $92 Million Series A Led by Novo Holdings to Advance Next-Generation Antibody-Drug Conjugates". San Francisco, CA. |
2024-10-28 |
| Ion Opticks Pty Ltd.. (10/25/24). "Press Release: Sciex and IonOpticks Announce Co-Marketing Agreement Between Aurora Series XS Range and the ZenoTOF Line". Melbourne. |
2024-10-25 |
| HepaRegenix GmbH. (10/22/24). "Press Release: HepaRegenix Appoints Dr. Martin Bonde as New Chair of the Board". Tübingen. |
2024-10-22 |
| H. Lundbeck A/S. (10/14/24). "Press Release: Lundbeck to Acquire Longboard Pharmaceuticals in a Strategic Deal, Significantly Enhancing Its Neuroscience Pipeline". Valby & La Jolla, CA. |
2024-10-14 |
| Booster Therapeutics GmbH. (10/10/24). "Press Release: Booster Therapeutics Launches to Pioneer New Class of Proteasome Activator Medicines for the Treatment of a Range of Complex Diseases". Berlin. |
2024-10-10 |
| Calluna Pharma AS. (10/9/24). "Press Release: Calluna Pharma Appoints Mark Gaffney as Chief Executive Officer and Mark Altmeyer as Independent Chair of the Board". Oslo & Boston, MA. |
2024-10-09 |
| Ferring Pharmaceuticals S.A.. (10/3/24). "Press Release: Ferring Bolsters Global Gene Therapy Supply Chain with European Manufacturing Facility". Saint-Prex. |
2024-10-03 |
| Evotec SE. (9/26/24). "Press Release: Evotec and Novo Nordisk Enter into Technology Development Partnership to Support Next-generation Cell Therapies". Hamburg. |
2024-09-26 |
| NanoVation Therapeutics Inc.. (9/18/24). "Press Release: NanoVation Therapeutics Announces Multi-Target Partnership with Novo Nordisk to Develop Genetic Medicines Targeting Cardiometabolic and Rare Diseases". Vancouver, BC. |
2024-09-18 |
| Bioké (Cell Signaling Technology Europe B.V.). (9/16/24). "Press Release: Bioké and e-Blot Announce a Distribution Agreement in the European Region". Leiden. |
2024-09-16 |
| Ion Beam Applications S.A. (IBA). (9/11/24). "Press Release: IBA’s Joint Venture PanTera Secures EUR 93 Million in Oversubscribed Series A Round to Accelerate Global Actinium-225 Production". Louvain-la-Neuve. |
2024-09-11 |
| Ion Opticks Pty Ltd.. (9/10/24). "Press Release: IonOpticks Partners with Adelis to Accelerate Global Expansion and Innovation". Melbourne & Stockholm. |
2024-09-10 |
| Agronomics Ltd.. (9/10/24). "Press Release: Formo Closes a US$ 61 Million Series B Round". |
2024-09-10 |
| Formo Bio GmbH. (9/10/24). "Press Release: Formo Bags $61 Million in Series B Funding – Launches the World’s First Animal-free Cheese Made with Koji Protein". |
2024-09-10 |
| Recipharm AB. (9/3/24). "Press Release: Recipharm Completes Divestment of Seven Sites". |
2024-09-03 |
| Alentis Therapeutics AG. (9/3/24). "Press Release: Alentis Appoints Jonathan Freve CFO". Basel. |
2024-09-03 |
| BioArctic AB. (8/22/24). "Press Release: Leqembi (lecanemab) Authorized for Early Alzheimer’s Disease in Great Britain". Stockholm. |
2024-08-22 |
| Adcendo ApS. (8/20/24). "Press Release: Adcendo ApS and Multitude Therapeutics Inc. Announce Global Development and Commercialization Agreement on First-in-class ADC Drug Candidate Targeting Tissue Factor". Copenhagen & Shanghai. |
2024-08-20 |
| Fujifilm Diosynth Biotechnologies UK Ltd.. (8/20/24). "Press Release: Fujifilm Diosynth Biotechnologies Celebrates Opening of Billingham, UK Microbial Manufacturing Facility". Billingham. |
2024-08-20 |
| Bavarian Nordic A/S. (8/8/24). "Press Release: Bavarian Nordic Receives USD 156.8 Million from the U.S. Government for Additional Smallpox/Mpox Vaccine Production". Copenhagen. |
2024-08-08 |
| Biomatter Designs. (8/5/24). "Press Release: Biomatter Raises a €6.5 Million Seed Round to Unlock the Power of Generative AI for Enzyme Design". Vilnius. |
2024-08-05 |
| Valneva S.E.. (7/22/24). "Press Release: CEPI Expands Partnership with Valneva with a $41.3 Million Grant to Support Broader Access to the World’s First Chikungunya Vaccine". Oslo & Saint-Herblain. |
2024-07-22 |
| Eisbach Bio GmbH. (7/18/24). "Press Release: Eisbach to Advance Training in Metabolic Regulation of Genome Function as Part of the EU-funded Research Network NUCLEAR". Munich. |
2024-07-18 |
| Draupnir Bio ApS. (7/1//24). "Press Release: Draupnir Bio Completes €12 Million Seed Round to Progress Development of Oral Small Molecule Degraders of Extracellular Proteins". Copenhagen. |
2024-07-17 |
| Asceneuron S.A.. (7/16/24). "Press Release: Asceneuron Secures $100 Million Series C Financing to Advance Groundbreaking Therapeutics in Neurodegenerative Diseases". Lausanne & San Francisco, CA. |
2024-07-16 |
| HepaRegenix GmbH. (7/10/24). "Press Release: HepaRegeniX Raises €15 Million Series C Round to Advance Clinical Development of HRX-215 for Liver Regeneration". Tübingen. |
2024-07-10 |
| Bico Group AB. (7/10/24). "Press Release: Andréas Joersjö Appointed as General Counsel for Bico Group AB". |
2024-07-10 |
![[LSS] Life-Sciences-Scandinavia.com - The Scandinavian Life Sciences Web Portal](/images/basics/lss-life-sciences-scandinavia-portal-logo.svg){kind=logo}
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
